40724 Federal Register / Vol. 63, No. 146 /Thursday, July 30, 1998 / Notices

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute on

Alcohol Abuse and Alcoholism Special

Emphasis Panel.

Date: July 28, 1998.

Time: 7:30 AM to 9:00 AM.

Agenda: To review and evaluate grant

applications.

Place: 600 Executive Blvd., Suite 409,

Rockville, MD 20852, (Telephone conference

Call).

Contact Person: Aida K. Vasquez, Grant

Technical Assistant, Extramural Review

Branch, National Institute on Alcohol Abuse

and Alcoholism Suite 409, 6000 Executive

Boulevard, Bethesda, MD 20892, 301–443–

9788.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: National Institute on

Alcohol Abuse and Alcoholism Special

Emphasis Panel.

Date: July 30, 1998.

Date: 9:00 AM to 10:30 AM.

Agenda: To review and evaluate grant

applications.

Place: 6000 Executive Blvd., Suite 409,

Rockville, MD 20852, (Telephone Conference

Call).

Contact Person: Aida K. Vasquez, Grant

Technical Assistant, Extramural Review

Branch, National Institute on Alcohol Abuse

and Alcoholism, Suite 409, 600 executive

Boulevard, Bethesda, MD 20892, 301–443–

9788.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.271, Alcohol Research

Career Development Awards for Scientists

and Clinicians; 93.272, Alcohol National

research Service Awards for Research

Training; 93.273, Alcohol Research Programs;

93.891, Alcohol Research Center Grants,

National Institutes of Health, HHS)

Dated: July 24, 1998.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 98–20292 Filed 7–29–98; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National institutes of Health

National Institute of Diabetes and

Digestive and Kidney Diseases; Notice

of Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of a meeting of the

National Diabetes and Digestive and

Kidney Diseases Advisory Council.

The meeting will be open to the

public as indicated below, with

attendance limited to space available.

Individuals who plan to attend and

need special assistance, such as sign

language interpretation or other

reasonable accommodations, should

notify the Contact Person listed below

in advance of the meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications

and/or contract proposals and the

discussions could disclose confidential

trade secrets or commercial property

such as patentable material, and

personal information concerning

individuals associated with the grant

applications and/or contract proposals,

the disclosure of which would

constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Diabetes and

Digestive and Kidney Diseases Advisory

Council.

Date: September 14–15, 1998.

Open: September 14, 1998, 8:30 AM to 2:00

PM.

Agenda: Grant applications.

Place: National Institutes of Health,

Building 31, Conference Room 10, Bethesda,

MD 20892.

Closed: September 14, 1998, 2:00 PM to

5:00 PM.

Agenda: To review and evaluate grant

applications.

Place: National Institutes of Health,

Building 31, Conference Room 10, Bethesda,

MD 20892.

Closed: September 15, 1998, 8:30 AM to

11:00 AM.

Agenda: To review and evaluate grant

applications.

Place: National Institutes of Health,

Building 31, Conference Room 10, Bethesda,

MD 20892.

Open: September 15, 1998, 11:00 AM to

adjournment.

Agenda: Grant applications.

Place: National Institutes of Health,

Building 31, Conference Room 10, Bethesda,

MD 20892.

Contact Person: Walter S. Stolz, PHD,

Director for Extramural Activities, National

Institute of Diabetes and Digestive and

Kidney Diseases, National Institutes of

Health, PHS, DHHS, Bethesda, MD 20892.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.847, Diabetes,

Endocrinology and Metabolic Research;

93.848, Digestive Diseases and Nutrition

Research; 93.849, Kidney Diseases, Urology

and Hematology Research, National Institutes

of Health, HHS)

Dated: July 24, 1998.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 98–20293 Filed 7–29–98; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute on Drug Abuse;

Notice of Closed Meetings

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meetings.

The meetings will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The contract proposals and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the contract

proposals, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute on

Drug Abuse Special Emphasis Panel. POSIT.

Date: July 28, 1998.

Time: 9:30 AM to 5:00 PM.

Agenda: To review and evaluate contract

proposals.

Place: DoubleTree Hotel, 1750 Rockville

Pike, Rockville, MD 20852.

Contact Person: Lyle Furr, Contract Review

Specialist, Office of Extramural Program

Review, National Institute on Drug Abuse,

National Institutes of Health, DHHS, 5600

Fishers Lane, Room 10–42, Rockville, MD

20857, (301) 443–1644.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: National Institute on

Drug Abuse Special Emphasis Panel. The

Drug Abuse and Alconol Problem

Assessment for Primary Care Evaluation of a

Substance Abuse Screening System.

Date: July 29, 1998.

Time: 10:00 AM to 11:00 AM.

Agenda: To review and evaluate contract

proposals.

Place: National Institute on Drug Abuse,

5600 Fishers Lane, Room 10–49, Rockville,

MD 20857 (Telephone Conference Call).

Contact Person: Eric Zatman, Contract

Review Specialist, Office of Extramural

Program Review, National Institute on Drug

Abuse, National Institutes of Health, DHHS,

5600 Fishers Lane, Room 10–42, Rockville,

MD 20857, (301) 443–1644.

Name of Committee: National Institute on

Drug Abuse Special Emphasis Panel.

Development of a Brief Drug Abuse

Screening Instrument.

Date: July 29, 1998.

Time: 11:00 AM to 12:00 PM.

Agenda: To review and evaluate contract

proposals.

Place: National Institute on Drug Abuse,

5600 Fishers Lane, Room 10–49, Rockville,

MD 20857 (Telephone Conference Call).